[Possibilities of combined topical intranasal glucocorticosteroid and antihistamine therapy in the treatment of allergic rhinitis for the relief of nasal obstruction and hyposmia].
Baranov K K KK, Kotova E N EN, Vyazmenov E O EO, Polunin M M MM et al.
Nasal obstruction and hyposmia are key symptoms of both allergic inflammation of the nasal mucosa and acute sinusitis/adenoiditis. The issue of optimal maintenance therapy after resolution of the acute process, especially in patients with AR, remains debatable. To evaluate the efficacy of mometasone furoate monotherapy and combined therapy with mometasone furoate and olopatadine in children and adults with seasonal and perennial AR complicated by acute sinusitis, with regard to the dynamics of nasal obstruction and olfactory function. A prospective comparative study was conducted in patients with seasonal and perennial allergic rhinitis complicated by acute sinusitis, with assessment of the dynamics of nasal obstruction and olfactory dysfunction. The study included 240 patients aged 6 to 60 years. After resolution of acute rhinosinusitis, the patients were assigned to observation groups and continued treatment for 1 month: group 1 received intranasal mometasone furoate 100-200 μg/day; group 2 received a combined mometasone furoate+olopatadine preparation according to the instructions for use; group 3 (control) received no maintenance antiallergic therapy. Treatment efficacy was assessed by evaluating nasal obstruction and olfactory function. A direct relationship was found between recovery of olfaction and nasal breathing and the selected maintenance therapy regimen after acute sinusitis. The combined approach (MF+O) was the most effective method, providing recovery of olfaction in 78% of patients (p<0.001). Combined topical therapy with INCS and an antihistamine has an advantage in reducing nasal obstruction and restoring olfaction compared with standard therapy or no maintenance antiallergic therapy. The findings support the feasibility of including combined topical preparations in treatment algorithms for patients with AR complicated by acute sinusitis.